Corrigendum: Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2 S,4 R)-4-¹⁸F-Fluoroglutamine

Front Immunol. 2022 Apr 12:13:902544. doi: 10.3389/fimmu.2022.902544. eCollection 2022.

Authors

Senthil Palani¹, Maxwell W G Miner¹, Jenni Virta¹, Heidi Liljenbäck^{1

2}, Olli Eskola¹, Tiit Örd³, Aarthi Ravindran³, Minna U Kaikkonen³, Juhani Knuuti^{1

4

5}, Xiang-Guo Li^{1

5}, Antti Saraste^{1

6}, Anne Roivainen^{1

2

4

5}

Affiliations

¹ Turku PET Centre, University of Turku, Turku, Finland.
² Turku Center for Disease Modeling, University of Turku, Turku, Finland.
³ A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
⁴ Turku PET Centre, Turku University Hospital, Turku, Finland.
⁵ InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
⁶ Heart Center, Turku University Hospital and University of Turku, Turku, Finland.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.821423.].

Keywords: 18F-fluoroglutamine; PET/CT; atherosclerosis; inflammation; macrophages.

Copyright © 2022 Palani, Miner, Virta, Liljenbäck, Eskola, Örd, Ravindran, Kaikkonen, Knuuti, Li, Saraste and Roivainen.

Publication types

Published Erratum